← Open Payments lookup

JACOB COLE: Open Payments

NPI 1194295527 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,724 in 147 payments from 17 companies in 2025. Trend: 2023 $45 · 2024 $903 · 2025 $2,724

Food & beverage: $2,724
CompanyPaymentsAmount
ABBVIE INC.25$476
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$384
Vanda Pharmaceuticals Inc.20$311
Teva Pharmaceuticals USA, Inc.11$239
Otsuka America Pharmaceutical, Inc.11$202
E.R. Squibb & Sons, L.L.C.6$160
Alkermes, Inc.6$152
Janssen Pharmaceuticals, Inc7$141
Collegium Pharmaceutical, Inc.11$139
Neurocrine BioSciences, Inc.5$115

Products named: VRAYLAR, CAPLYTA, FANAPT, AUSTEDO XR, COBENFY, ARISTADA, Jornay PM, INGREZZA.

Industry payments across NV — which companies pay providers there.